Status:
COMPLETED
An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at Bedtime
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
Brief Summary
This study is conducted in Europe. The aim of this study is investigate the potential of a supplementary insulin therapy regimen (SIT) as intensification for insufficiently controlled patients with ty...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Type 2 diabetes
- OAD monotherapy
- OAD combination therapy
- Therapy with OAD and basal insulin
- Conventional insulin therapy with premixed insulin
Exclusion
Key Trial Info
Start Date :
July 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2006
Estimated Enrollment :
2134 Patients enrolled
Trial Details
Trial ID
NCT01487421
Start Date
July 1 2003
End Date
October 1 2006
Last Update
June 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mainz, Germany, 55127